Related Experiment Video
Updated: Feb 11, 2026
08:02
Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
6.6K
Nanoparticles in cancer chemotherapy
Deboshri Banerjee1, Shiladitya Sengupta
1BWH-HST Center for Biomedical Engineering, Department of Medicine,Brigham and Women’s Hospital, Harvard Medical School, Harvard-MIT Division of Health Science and Technology, Cambridge, Massachusetts, USA
Progress in Molecular Biology and Translational Science
|November 19, 2011
Summary
Nanotechnology offers advanced nanoparticle drug delivery systems for improved cancer chemotherapy. These nanocarriers enhance drug efficacy, reduce toxicity, and target tumors more effectively.
Area of Science:
- Oncology
- Materials Science
- Pharmacology
Background:
- Nanotechnology presents a promising frontier in cancer research, aiming to enhance existing cancer therapeutics.
- Nanoparticles offer significant advantages over conventional free drugs in cancer treatment.
Purpose of the Study:
- To explore the role of nanotechnology in improving cancer chemotherapy.
- To discuss the physicochemical properties of nanoparticles and their impact on tumor targeting.
Main Methods:
- Review of current literature on nanoparticle applications in cancer therapy.
- Analysis of nanoparticle physicochemical properties and their influence on drug delivery.
Main Results:
- Nanoparticles can carry high drug payloads, prolong drug half-life, and reduce systemic toxicity.
- Enhanced tumor targeting efficiency is a key benefit of nanoparticle-based drug delivery.
Conclusions:
- Nanoparticles offer tunable pharmacological properties for optimized cancer treatment.
- The clinical application of nanoparticles in cancer chemotherapy is expanding, showing significant potential.
Related Concept Videos
02:18Cancer
54.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.4K
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
796
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
796
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
922
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
922
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
699
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
699
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
639
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
639
02:12What is Cancer?
14.5K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.5K